Systemic mastocytosis and bone involvement in a cohort of 75 patients
about
Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and managementMast Cell Clonal Disorders: Classification, Diagnosis and ManagementDiagnosis and treatment of mast cell disorders: practical recommendations.Long-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT.Protective Effects of Alisma orientale Extract against Hepatic Steatosis via Inhibition of Endoplasmic Reticulum Stress.Mast Cell-Mediated Mechanisms of Nociception.Mastocytosis: oral implications of a rare disease.Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options.Update on diagnosis and treatment of mastocytosis.Advanced imaging of skeletal manifestations of systemic mastocytosis.Osteoporosis in young adults: pathophysiology, diagnosis, and management.Diagnosis, progression patterns and prognostication in mastocytosis.Mastocytosis: update on pharmacotherapy and future directions.Current treatment options in patients with mastocytosis: status in 2015 and future perspectives.Chronic myeloproliferative neoplasms and risk of osteoporotic fractures; a nationwide population-based cohort study.Bone morbidity in chronic myeloproliferative neoplasms.Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.Endocrine manifestations of systemic mastocytosis in bone.Association between rheumatoid arthritis and systemic mastocytosis: a case report and literature review.Bone mineral density and microarchitecture in patients with essential thrombocythemia and polycythemia vera.Osteoporotic spinal burst fracture in a young adult as first presentation of systemic mastocytosis.Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.Bone geometry, bone mineral density, and micro-architecture in patients with myelofibrosis: a cross-sectional study using DXA, HR-pQCT, and bone turnover markers.Targeted Treatment Options in Mastocytosis.Orthopaedic case of the month: Recurrent thigh pain in a 44-year-old man.High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis.Disease spectrum in patients with elevated serum tryptase levels.Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis.Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis.Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions.Effects of the Histamine 1 Receptor Antagonist Cetirizine on the Osteoporotic Phenotype in H(+) /K(+) ATPase Beta Subunit KO Mice.[Severe therapy refractive osteoporosis : A rare differential diagnosis].
P2860
Q27025982-1202B58D-0F39-4E6A-BF8B-3C94570C69F1Q28070386-2262BE5E-C112-4E68-94CF-A86D7F95EFE9Q35021196-E1F4F245-870C-4442-B296-CA3D4EDE92DBQ35153623-10223B77-F93D-4F8E-8B79-6200C4062F8DQ36324486-7E4C0AF6-50AE-446F-8F2A-7BC9CCAE3897Q36404141-050D2363-8054-4E64-B36A-EF9F3F5DA4BAQ37825551-620D0690-127B-4BEB-8278-8A651562D762Q37854888-756CF1A7-4C23-448B-98B5-6134262B88A8Q37869373-5F0A5E34-FE11-4CB5-B540-A205746F66EEQ37988308-1AE1FDF2-DEEA-497D-9A4A-2690918CEBC7Q38017609-FD9EB314-FB0F-4C2C-85F1-E542A37C2EA7Q38025156-B5E09351-EDC2-4C32-8AAD-6FF39F6A3E4FQ38138597-6EF0518B-D2D0-4673-99FE-AC1E571A009BQ38370943-A6356C50-2AA4-4109-AE6E-71ACF01EE37CQ38424081-58D4C13A-B8D2-4CC7-A77D-C70680ED760CQ38513219-CCEE1C4C-89F8-484B-93E5-A5F42A3A8DD1Q38582624-F4332086-F9F3-4123-93AE-00AB1ABD8438Q38739710-2AF7A2B7-CA47-4BEB-BDF4-A11C53CF87D7Q38848019-C587D295-28C8-47B3-A482-0FFC6551AF8CQ38923398-0C20F85E-223A-4ACB-B072-865EA1372EC0Q40544293-135666A3-EF0F-40B3-969A-A4807AE7DB1AQ40871762-4B88961C-4A81-43C5-B193-F8FF6C38B6FCQ40976858-A415B0BF-DA0A-4662-96EE-75B2FE8CA5F7Q40978238-0D7EADAF-B00D-421A-BD9E-A32CC4B952C0Q41061871-1EB72374-EFB5-4B45-90C9-2E9392278630Q41832281-C227E4CC-9044-42F0-84EA-E8D55EC3DA90Q44277294-0DD09053-D363-4895-9EE0-7FF908181537Q45897925-6010BA4B-9F83-4B8E-8EF7-3B862A1AC6C6Q46287428-BB91BC45-18B8-4EBF-982C-FD355A9F6333Q47158405-26D5237D-84FD-4077-B270-411400D9302CQ47997702-1A838943-8A8F-4497-A87E-7005BAD01152Q50931979-AC0152A1-BEE0-4319-B7A6-1F3CD9C35E2EQ52852170-1EAD30AA-056E-4110-B464-BB50BB7E3DF9
P2860
Systemic mastocytosis and bone involvement in a cohort of 75 patients
description
im Juni 2010 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2010
@uk
name
Systemic mastocytosis and bone involvement in a cohort of 75 patients
@en
Systemic mastocytosis and bone involvement in a cohort of 75 patients
@nl
type
label
Systemic mastocytosis and bone involvement in a cohort of 75 patients
@en
Systemic mastocytosis and bone involvement in a cohort of 75 patients
@nl
prefLabel
Systemic mastocytosis and bone involvement in a cohort of 75 patients
@en
Systemic mastocytosis and bone involvement in a cohort of 75 patients
@nl
P2093
P356
P1476
Systemic mastocytosis and bone involvement in a cohort of 75 patients
@en
P2093
B. Billemont
C. Frances
C. Grandpeix
C. de Gennes
D. Canioni
F. Lanternier
F. Palmerini
P304
P356
10.1136/ARD.2009.124511
P407
P577
2010-06-22T00:00:00Z